IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 66 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $54,000 | -25.0% | 41,100 | +5.1% | 0.00% | – |
Q1 2018 | $72,000 | -7.7% | 39,100 | +5.4% | 0.00% | – |
Q4 2017 | $78,000 | -19.6% | 37,100 | -14.9% | 0.00% | – |
Q3 2017 | $97,000 | +29.3% | 43,600 | 0.0% | 0.00% | – |
Q2 2017 | $75,000 | -85.1% | 43,600 | -78.6% | 0.00% | -100.0% |
Q1 2017 | $504,000 | +60.0% | 204,213 | -2.9% | 0.00% | +50.0% |
Q4 2016 | $315,000 | -6.2% | 210,213 | +60.3% | 0.00% | 0.0% |
Q3 2016 | $336,000 | +80.6% | 131,100 | +8.1% | 0.00% | +100.0% |
Q2 2016 | $186,000 | -13.5% | 121,300 | +11.8% | 0.00% | -50.0% |
Q1 2016 | $215,000 | -40.3% | 108,500 | -6.9% | 0.00% | -33.3% |
Q4 2015 | $360,000 | +2.9% | 116,500 | +11.5% | 0.00% | 0.0% |
Q3 2015 | $350,000 | +548.1% | 104,500 | +620.7% | 0.00% | – |
Q2 2015 | $54,000 | 0.0% | 14,500 | 0.0% | 0.00% | -100.0% |
Q1 2015 | $54,000 | +5.9% | 14,500 | +26.1% | 0.00% | 0.0% |
Q4 2014 | $51,000 | +104.0% | 11,500 | +4.5% | 0.00% | – |
Q3 2014 | $25,000 | -16.7% | 11,000 | +4.8% | 0.00% | – |
Q2 2014 | $30,000 | -26.8% | 10,500 | +5.0% | 0.00% | -100.0% |
Q1 2014 | $41,000 | – | 10,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Virtus ETF Advisers LLC | 474,609 | $626,000 | 0.55% |
Kassirer Asset Management Corp | 325,800 | $430,000 | 0.28% |
CORRADO ADVISORS, LLC | 104,850 | $138,000 | 0.08% |
Artal Group S.A. | 2,750,000 | $3,630,000 | 0.08% |
ROPES WEALTH ADVISORS LLC | 100,000 | $132,000 | 0.04% |
MYCIO WEALTH PARTNERS, LLC | 246,527 | $325,000 | 0.03% |
Palo Alto Investors LP | 616,355 | $814,000 | 0.03% |
HOLLENCREST CAPITAL MANAGEMENT | 172,570 | $228,000 | 0.03% |
LAU ASSOCIATES LLC | 26,713 | $35,000 | 0.02% |
NATIXIS | 3,438,529 | $4,539,000 | 0.02% |